4//SEC Filing
Hontecillas Raquel 4
Accession 0001209191-21-007481
CIK 0001785345other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:47 PM ET
Size
5.6 KB
Accession
0001209191-21-007481
Insider Transaction Report
Form 4
Hontecillas Raquel
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-03+250,604→ 250,604 totalExercise: $16.00Exp: 2031-02-02→ Common Stock (250,604 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this option vested and became exercisable as to 25% of the shares underlying this option on January 26, 2021, an additional 25% of the shares underlying this option will vest and become exercisable on January 26, 2022, and the remaining 50% thereafter in 24 equal monthly installments, subject to the Reporting Person's continuous service with the Issuer on each such date.
Documents
Issuer
Landos Biopharma, Inc.
CIK 0001785345
Entity typeother
Related Parties
1- filerCIK 0001843703
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:47 PM ET
- Size
- 5.6 KB